Abstract
Data concerning 40 patients hospitalized in a cancer center andSalmonella infection were analyzed. Hematological malignancy was present in 24 patients (60%) and solid tumor in 14 patients (35%). Among the predisposing factors, antineoplastic chemotherapy was the most frequent (60%) followed by antacid use (47.5%), corticosteroids (37.5%), granulocytopenia below 500 neutrophils/μl (15%), surgery (10%) and splenectomy (2.5%). Bacteremia was the most frequent clinical syndrome accounting for 42.5% of the patients. Focal infection, enteritis and carrier state accounted for the remaining 30%, 20% and 7.5% respectively.Salmonella typhimurium andS. dublin represented 65% of the isolates, with clear association between serotypedublin and bacteremia. AllS. dublin isolates were resistant to chloramphenicol. Amongdublin andtyphimurium serotypes, 20% the isolates were resistant to the traditional antibiotics used in salmonellosis (ampicillin, chloramphenicol, cotrimoxazole). All strains were susceptible in vitro to cephalosporins. The frequency of relapse was 15% and the overall mortality (within 30 days) attributed toSalmonella infection was 15%.
Similar content being viewed by others
References
Asperilla MA, Smego RA Jr, Scott LK (1990) Quinolone antibiotics in the treatment ofSalmonella infections. Rev Infect Dis 12:873–889
Bibel DJ, Aly R, Bayles C, Straus WG, Shinefiels HJ, Paibach HI (1983) Competitive adherence as a mechanism of bacterial interference. Can J Microbiol 29:700–703
Berk MR, Meyers AM, Cassel W, Botha JR, Myburgh JA (1984) NontyphoïdSalmonella infections after renal transplantation: a serious clinical problem. Nephron 37:186–189
Bodey GP, Buckley M, Saythe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328–340
Bohnhoff M, Miller CP, Martin WR (1964) Resistance of the mouse's intestinal track to experimentalSalmonella infections. J Exp Med 120:805–816
Bottone EJ, Wormser GP, Duncanson EP (1984) NontyphoïdalSalmonella bacteremia as an early infection in acquired immunodeficiency syndrome. Diagn Microbiol Infect Dis 2:247–250
Bryan JP, Roche H, Sheld M (1986) Problems in salmonellosis: rationale for clinical trials with newer β lactam agents and quinolones. Rev Infect Dis 8:189–207
Celum CL, Chaisson RE, Rutherford GW, Barnhart JL, Echengerg DF (1987) Incidence of salmonellosis in patients with AIDS. J Infect Dis 156:998–1002
Cherubin CE, Neu HC, Imperato PJ, Harvey RP, Bellin N (1974) Septicemia with non-typhoïdSalmonella. Medicine 53:365–376
Cohen RA, Geraci JE, Dearing WH, Needham GM (1964) Salmonellosis: observation on 94 patients. Proc Mayo Clin 39:401–409
Davidson JN, Hirsh DC (1972) Use of the K 88 antigen for in vivo bacterial competition with porcine strain of enteropathogenicE. coli. Infect Immun 12:134–136
De Wit S, Taelman H, Van de Perre P, Rounoy D, Clumeck N (1988)Salmonella bacteremia in african patients with human immunodeficiency virus infection. Eur J Clin Microbiol Infect Dis 7:45–47
Fishel MA, Dickison GM, Sinave C, Pitchenik AE, Clearly TJ (1986)Salmonella bacteremia as manifestation of acquired immunodeficiency syndrome. Arch Intern Med 146:113–115
Freter R, Brickner H, Botney M, Cleven D, Arnaki A (1983) Mechanism that control bacterial population in continuous-flow culture models of mouse large intestinal flora. Infect Immun 39:676–685
Gianella RA, Broitman SA, Zamcheck N (1971)Salmonella enteritis. I. Role of reduced gastic secretion in pathogenesis. Am J Dig Dis 16:1000–1006
Glasser JB, Morton-Kute L, Berger SR, Weber J, Siegal FP, Lopez C, Robbins W, Landesmans SH (1985) RecurrentSalmonella typhimurium bacteremia associated with the acquired immunodeficiency syndrome. Ann Intern Med 102:189–193
Guerrant RL (1989) Principles and syndrome of enteric infection. In: Mandell MG, Douglas RG, Bennett JE (eds) Principles and practice of infectious diseases, 3rd edn. Churchill Livingstone, New York, pp 837–851
Han T, Soral J, Neter E (1967) Salmonellosis in disseminated malignant diseases. A seven year review. N Engl J Med 276:1045–1052
Hentges DJ (1970) Enteric pathogen normal flora interactions. Am J Clin Nutr 23:1451–1456
Hook EW (1961) Salmonellosis: certain factors influencing the interaction ofSalmonella and the human host. Bull NY Acad Med 37:499–512
Hook EW (1989)Salmonella species (including typhoïd fever). In: Mandell CL, Douglas RG, Bennett JE (eds) Principles and practice of infectious diseases, 3rd edn. Churchill Livingstone, New York, pp 1700–1716
Mac Cleady RA, Reardon JP, Saphra I (1957) Salmonellosis in Massachusetts: a 16 years experience. N Engl J Med 256:1121–1128
Mandal BK (1989) Typhoid fever and otherSalmonellae. Curr Opinion Infect Dis 2:101–105
Meynell GG (1963) Antibacterial mechanisms of the mouse gut. II. The role of Eh and volatile fatty acids in the normal gut. Br J Exp Pathol 44:209–219
Nadelman RB, Mathun-Wagh V, Yancovitz SR, Milduan D (1985)Salmonella bacteremia associated with the Acquired Immunodeficiency Syndrome (AIDS). Arch Intern Med 145:1968–1971
Que JV, Casey SN, Hentges DJ (1986) Factors responsible for increased susceptibility of mice to intestinal colonization after treatment with streptomycin. Infect Immun 53:116–123
Samra Y, Shaked Y, Naier M (1986) Nontyphoïd salmonellosis in renal transplant recipients: report of five cases and review of the literature. Rev Infect Dis 8:431–440
Sinkovics JG, Smith JP (1969) Salmonellosis complicating neoplastic diseases. Cancer 24:631–636
Smith PD, Macher AM, Bookman MA, Boccic RV, Sters RG, Gill V, Manischevitz J, Gelmann EP (1985)Salmonella typhimurium enteritis and bacteremia in the acquired immuno-deficiency syndrome. Ann Intern Med 102:207–209
Soe GB, Overturf GD (1987) Treatment of typhoïd fever and other systemic salmonellosis with cefotaxime, ceftriaxine, cefoperazone and other newer cephalosporins. Rev Infect Dis 9:719–736
Sperber S, Schleupuer C (1987) Salmonellosis during infection with immunodeficiency virus. Rev Infect Dis 9:925–934
Taylor DN, Bied JM, Munro JS, Feldman RA (1982)Salmonella dublin infections in United States, 1979–1980. J Infect Dis 146:322–327
Van der Meer JW (1988) Defects in host defence mechanism. In: Rubin RH, Young LS (eds) Clinical approach to infection in the compromised host, 2nd edn. Plenum Press, New York, pp 41–73
Wade JC, Jongh CA de, Newman KA, Crowley J, Wiernik PH, Schimpff SC (1983) Selective antimicrobial modulation as prophylaxis against infections during granulocytopenia: trimethoprim-sulfamethoxazole vs nalidixic acid. J Infect Dis 147:624–634
Wolfe MS, Armstrong D, Louria D, Blevins A (1971) Salmonellosis in patients with neoplastic disease. Arch Intern Med 128:546–554
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Noriega, L.M., van der Auwera, P., Daneau, D. et al. Salmonella infections in a cancer center. Support Care Cancer 2, 116–122 (1994). https://doi.org/10.1007/BF00572093
Issue Date:
DOI: https://doi.org/10.1007/BF00572093